Phase I clinical study of a new radiopharmaceutical based on recombinant target molecules DARPin9_29 labeled with technetium-99m for radionuclide diagnosis of the Her2/neu-positive breast cancer

Autor:	Olga Dmitrievna Bragina, Vladimir Ivanovich Chernov, Maria Sergeevna Larkina, Elene Sergeevna Stasyuk, Roman Vladimirovich Zelchan, Anna Aleksandrovna Medvedeva, Evgeny Yurievich Garbukov, Roman Yurievich Vernadskyi, Sergey Mikhailovich Deev, Vladimir Maximilianovich Tolmachev
Rok vydání:	2021
Zdroj:	Molekulyarnaya Meditsina (Molecular medicine). 19:41-48
ISSN:	2499-9490 1728-2918
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ad57dfc4f70bc9e802472ca41d25beef https://doi.org/10.29296/24999490-2021-02-06 Zobrazit plný text záznamu